{"id":"https://openalex.org/W7220984860","doi":"https://doi.org/10.5281/zenodo.23221690","title":"Method Development, Optimization And Validation For Simultaneous Estimation Of Dapagliflozin And Bisoprolol In Active Pharmaceutical Ingredient And Pharmaceutical Dosage Form By RP-HPLC Method","display_name":"Method Development, Optimization And Validation For Simultaneous Estimation Of Dapagliflozin And Bisoprolol In Active Pharmaceutical Ingredient And Pharmaceutical Dosage Form By RP-HPLC Method","publication_year":2026,"publication_date":"2026-10-07","ids":{"openalex":"https://openalex.org/W7220984860","doi":"https://doi.org/10.5281/zenodo.23221690"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.23221690","doi":"https://doi.org/10.5281/zenodo.23221690","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23221690","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.23221690","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5157961058","display_name":"V. Amritha1*, D. Jothieswari2, B. Swarupa3","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"V. Amritha1*, D. Jothieswari2, B. Swarupa3","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5157961058"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bisoprolol","display_name":"bisoprolol","score":1.0},{"id":"https://openalex.org/keywords/joint-estimation","display_name":"simultaneous estimation","score":0.8410000205039978},{"id":"https://openalex.org/keywords/rp-hplc-method-development","display_name":"RP-HPLC method development","score":0.8410000205039978},{"id":"https://openalex.org/keywords/method-validation","display_name":"method validation","score":0.7879999876022339},{"id":"https://openalex.org/keywords/tablets","display_name":"tablets","score":0.6309999823570251},{"id":"https://openalex.org/keywords/active-pharmaceutical-ingredients","display_name":"active pharmaceutical ingredients","score":0.753000020980835},{"id":"https://openalex.org/keywords/combination-drug-products","display_name":"combination drug products","score":0.7160000205039978},{"id":"https://openalex.org/keywords/pharmaceutical-assay","display_name":"pharmaceutical assay","score":0.5740000009536743},{"id":"https://openalex.org/keywords/isocratic-separation","display_name":"isocratic separation","score":0.4259999990463257},{"id":"https://openalex.org/keywords/uv-detection","display_name":"UV detection","score":0.5580000281333923},{"id":"https://openalex.org/keywords/detection-limit","display_name":"detection limit","score":0.49799999594688416},{"id":"https://openalex.org/keywords/limit-of-quantification","display_name":"limit of quantification","score":0.9789999723434448},{"id":"https://openalex.org/keywords/accuracy-and-precision","display_name":"precision and accuracy","score":0.6840000152587891},{"id":"https://openalex.org/keywords/pharmaceutical-quality-control","display_name":"pharmaceutical quality control","score":0.4399999976158142},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.9276000261306763},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.7524999976158142},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.7445999979972839},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.6559000015258789},{"id":"https://openalex.org/C2779670145","wikidata":"https://www.wikidata.org/wiki/Q412515","display_name":"Bisoprolol","level":3,"score":0.6111999750137329},{"id":"https://openalex.org/C119128265","wikidata":"https://www.wikidata.org/wiki/Q900165","display_name":"Detection limit","level":2,"score":0.5164999961853027},{"id":"https://openalex.org/C106186310","wikidata":"https://www.wikidata.org/wiki/Q1437823","display_name":"Pharmaceutical formulation","level":2,"score":0.4823000133037567},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41999998688697815},{"id":"https://openalex.org/C3020018676","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Retention time","level":2,"score":0.39480000734329224},{"id":"https://openalex.org/C2779607525","wikidata":"https://www.wikidata.org/wiki/Q14982","display_name":"Methanol","level":2,"score":0.3181000053882599},{"id":"https://openalex.org/C79191276","wikidata":"https://www.wikidata.org/wiki/Q7259620","display_name":"Pulsatile flow","level":2,"score":0.3084999918937683},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.28859999775886536},{"id":"https://openalex.org/C2992520659","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatographic separation","level":3,"score":0.2791000008583069},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.26899999380111694},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.2678000032901764},{"id":"https://openalex.org/C172120300","wikidata":"https://www.wikidata.org/wiki/Q1134348","display_name":"Volumetric flow rate","level":2,"score":0.260699987411499},{"id":"https://openalex.org/C138268822","wikidata":"https://www.wikidata.org/wiki/Q1051925","display_name":"Resolution (logic)","level":2,"score":0.25049999356269836}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.23221690","doi":"https://doi.org/10.5281/zenodo.23221690","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23221690","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.23221691","doi":"https://doi.org/10.5281/zenodo.23221691","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23221691","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.23221690","doi":"https://doi.org/10.5281/zenodo.23221690","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23221690","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7124450888","https://openalex.org/W7116962573","https://openalex.org/W7168528134","https://openalex.org/W6912142185","https://openalex.org/W7204166865","https://openalex.org/W4411457683","https://openalex.org/W7128298702","https://openalex.org/W7154562448","https://openalex.org/W4415277053","https://openalex.org/W7126275608"],"abstract_inverted_index":{"Background:":[0],"Simultaneous":[1],"quantitative":[2],"analysis":[3],"of":[4,13,35,66,105,111,140,145,156,184,214,233,242],"combination":[5],"drug":[6,72],"products":[7],"requires":[8],"a":[9,53,82,102,108],"chromatographic":[10],"procedure":[11,238],"capable":[12],"providing":[14],"adequate":[15],"separation,":[16],"reproducible":[17],"response":[18],"and":[19,38,51,58,68,73,94,114,121,127,143,162,176,186,194,202,206,222,244,250,263],"acceptable":[20],"analytical":[21],"performance.":[22],"Reverse-phase":[23],"high-performance":[24],"liquid":[25],"chromatography":[26],"(RP-HPLC)":[27],"is":[28],"widely":[29],"used":[30],"for":[31,63,132,160,165,174,179,204,220,224,239],"pharmaceutical":[32],"assay":[33,241],"because":[34,275],"its":[36],"versatility":[37],"compatibility":[39],"with":[40,181],"UV":[41,115],"detection.":[42],"Objective:":[43],"The":[44,149,167,227],"present":[45],"study":[46],"aimed":[47],"to":[48],"develop,":[49],"optimize":[50],"validate":[52],"simple,":[54],"accurate,":[55],"precise,":[56],"robust":[57],"cost-effective":[59],"isocratic":[60,236],"RP-HPLC":[61,237],"method":[62,129,151],"simultaneous":[64],"estimation":[65],"dapagliflozin":[67,161,175,205,221,243],"bisoprolol":[69,245,258],"in":[70,246],"bulk":[71,249],"tablet":[74,122,251],"dosage":[75],"form.":[76],"Methods:":[77],"Separation":[78],"was":[79,130,192,200,210,218],"developed":[80,235],"on":[81],"C18":[83],"column":[84],"(250":[85],"\u00d7":[86],"4.6":[87],"mm":[88],"i.d.,":[89],"5":[90,217],"\u00b5m)":[91],"using":[92],"methanol":[93],"citric-acid":[95],"buffer":[96],"as":[97],"the":[98,128,231,234,247,256,270,276],"mobile":[99],"phase":[100],"at":[101,117],"reported":[103,153,228],"ratio":[104],"64:36%":[106],"v/v,":[107],"flow":[109],"rate":[110],"1.0":[112],"mL/min":[113],"detection":[116,141],"227":[118],"nm.":[119],"Standard":[120],"sample":[123],"solutions":[124],"were":[125],"prepared":[126],"evaluated":[131],"specificity,":[133],"linearity,":[134],"precision,":[135],"accuracy,":[136],"robustness,":[137],"ruggedness,":[138],"limit":[139,144],"(LOD)":[142],"quantification":[146],"(LOQ).":[147],"Results:":[148],"optimized":[150],"produced":[152],"retention":[154],"times":[155],"approximately":[157,211],"2.86":[158],"min":[159,164],"14.20":[163],"bisoprolol.":[166,225],"thesis":[168,278],"reports":[169],"linearity":[170,259],"over":[171],"10\u201330":[172],"\u00b5g/mL":[173,178],"5\u201325":[177],"bisoprolol,":[180,207],"correlation":[182],"coefficients":[183],"0.9995":[185],"0.9992,":[187],"respectively.":[188],"Interday":[189],"%":[190,198],"RSD":[191,199],"1.007%":[193],"0.08872%,":[195],"while":[196],"intraday":[197],"0.2694%":[201],"0.3349%":[203],"respectively.Mean":[208],"recovery":[209],"99\u2013101%.":[212],"Assay":[213],"Gluxit":[215],"Beta":[216],"99.39%":[219],"100.68%":[223],"Conclusion:":[226],"findings":[229],"support":[230],"suitability":[232],"routine":[240],"investigated":[248],"samples.":[252],"Before":[253],"journal":[254],"submission,":[255],"pH,":[257],"range,":[260],"regression":[261],"data":[262],"LOD/LOQ":[264],"values":[265],"should":[266],"be":[267],"checked":[268],"against":[269],"original":[271],"laboratory":[272],"calculation":[273],"sheets":[274],"source":[277],"contains":[279],"internal":[280],"inconsistencies.":[281]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-10-09T00:00:00"}